Sale of 765 shares at $207.3201 per share.
Reporting Person Cislini Jeff · Officer Title SVP & General Counsel · Transaction Code S
Traded Sep 25, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001969082-26-000011 · filed 2026-09-29 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-09-29. https://desqlong.com/cards/0001969082-26-000011-1 (retrieved 2026-09-30).